Skip to main content

      With healthcare access expanding rapidly to its 700 million plus population, Southeast Asia (SEA) is seeing sustained increases in infrastructure investment, procedural volumes and demand for higher‑quality care. Governments across SEA are actively prioritizing healthcare system expansion and MedTech adoption, creating a strong, long‑term demand outlook that global MedTech companies cannot ignore.

      MedTech demand in SEA is shifting from episodic to recurring, requiring fast‑responding supply chains that can replenish continuously. However, most current MedTech supply chain models are designed for stability within individual markets and not for coordinated growth across a fragmented region. As SEA demand accelerates, these models come under strain, leading to slower responses, higher costs and constrained expansion.

      Key imperatives for MedTech companies and the industry to scale effectively

      These imperatives are linked but demand varying degrees of leadership attention and typically follow a sequence:

      MedTech companies:
      • Build end-to-end visibility
      • Strengthen the distributor ecosystem
      • Design selective localization networks
      Industry-wide:
      • Drive collaborative industry-level action
      Download

      Building a future ready MedTech supply chain for Southeast Asia — Executive Summary

      Download

      Building a future ready MedTech supply chain for Southeast Asia — Main Report

      Our insights

      Tailoring MedTech solutions to Southeast Asia‘s unique healthcare needs

      Key considerations to help improve trust, access and adoption of AI in MedTech

      A snapshot on technology adoption, investment, and value realization

      Our people

      Sari Mackay

      National Sector Lead, Industrial Markets

      KPMG Australia

      Guillaume Sachet

      Head of Healthcare & Life Sciences

      KPMG in Singapore